ENGN (enGene Holdings Inc) Net Profit

ENGN (enGene) - company brandmark

The current share price of enGene Holdings Inc. (ENGN) shown on the chart correlates with management's efforts to secure partners and advance new drug trials, with the indicator standing at -0.13. enGene Holdings Inc. (ENGN) specializes in developing immune-boosting agents and innovative therapies. The development of such products requires exclusive patents and massive safety expenditures, creating high barriers to entry within the industry.

ENGN (enGene Holdings Inc.) Net Profit history from 02/21/2024 to 11/02/2026

Analytical breakdowns and data insights for company enGene (ENGN)

- price and consensus price forecast:
Stock Quotes enGene Corp|ENGN - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization enGene Corp|ENGN - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share enGene|ENGN - Book Capitalization|Market Capitalization to Book Value engene.com|ENGN - Aggregate Company Assets
- debt and solvency information:
Total Debt to Equity Ratio enGene Holdings Inc.|ENGN - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio enGene Holdings Inc|ENGN - Company Total Debt|Debts to Book Capitalization enGene Corp|ENGN - Company Long-Term Debt|Company Short-Term Indebtedness enGene|Immediate Liquidity engene.com
- net income and valuation multiples indicators:
ENGN - Net Profit
Summary company analysis:enGene Holdings Inc.
Core merchandise of enGene Bio

enGene Holdings Inc. profit represents a daily calculation of operational efficiency used to determine the business's real value. Investors utilize this indicator as an objective marker of long-term growth potential. Analyzing the company's net income allows for tracking the development trajectory of enGene Holdings Inc. Current price action reflects the resilience of demand for gene therapy, although metric volatility may signal logistical disruptions or patent risks.

Main competitors

Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|Intrexon - Net Profit|Company Net Income Pharming Corp|Nektar Therapeutics (NKTR) - Company Net Income|Company Profit UPB|ZBIO (Zenas Biopharma) - Net Profit|IMNM - Annual Net Income|Net Profit GOSS|KALV - Company Net Income|Company Net Income Septerna Inc SEPN|PVLA: Company Profit|Savara - Net Profit|Company Net Income Rigel Pharma|ANAB (AnaptysBio Corp) - Net Income|Astria Corp - Final Profit|RAPT (RAPT Therapeutics, Inc.) - Net Profit|JBIO: Final Profit|Company Net Income Aclaris Therapeutics, Inc. (ACRS)|KYTX - Company Net Income|Company Net Income Tiziana Life Sciences PLC TLSA|Cabaletta Bio Inc - Company Net Income|Ventyx Biosciences - Net Profit|THTX (theratech.com) - Company Profit|AVTX: Net Profit|ELDN - Net Financial Result|Company Net Income Agenus Inc|Company Profit CLYM (Climb Bio, Inc)|Net Profit ZURA|atyrpharma.com (ATYR) - Annual Net Income|Company Net Income Adagene Inc. ADAG|Net Financial Result ImageneBio (IMA)|STTK: Net Income|Final Profit EQ (Equillium, Inc.)|CNTB: Net Profit|IMUX - Net Financial Result|Company Net Income Atara Biotherapeutics, Inc.|Company Profit IFRX (InflaRx GmbH)|Net Profit XFOR|Net Income adicetbio.com ACET|Celularity - Net Income|Net Financial Result inmunebio.com (INMB)|Barinthus Biotherapeutics plc - Net Profit|Company Net Income Kezar Life Sciences Inc.|SAB Biotherapeutics, Inc (SABS) - Company Net Income|Company Profit AKTX|ENLV (Enlivex Therapeutics Ltd) - Net Profit|QTTB - Annual Net Income|Company Net Income GeoVax (GOVX)|Edesa Biotech Inc - Company Profit|Company Net Income iBio Corp IBIO|CARM (Carisma Therapeutics Inc) - Profit After Tax|XTL Biopharmaceuticals - Net Profit|Final Profit BOLT (Bolt Biotherapeutics)|HCWB: Net Profit|Aptevo Therapeutics Inc. (APVO) - Net Profit|Company Net Income AIM ImmunoTech|ADTX: Final Profit|Company Net Income GRI Bio, Inc. (GRI)|Net Income xortx.com XRTX|Net Profit HIND (Vyome Holdings)|Net Profit Revelation Biosciences Inc REVB|INDP: Net Income|Final Profit SCNI (BiondVax Pharmaceuticals)|CALI: Net Profit|AFMD - Net Financial Result|Company Net Income Allakos Inc|Net Income HOOKIPA (HOOK)|Company Net Income IGM Biosciences, Inc. (IGMS)|Net Income iTeos Pharma ITOS|Ocean Biomedical, Inc. - Net Income|Net Profit tcbiopharm.com TCBP|THRD - Company Net Income